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Conventional and genetic evidence on alcohol and vascular 
disease aetiology: a prospective study of 500 000 men and 
women in China
Iona Y Millwood*, Robin G Walters*, Xue W Mei, Yu Guo, Ling Yang, Zheng Bian, Derrick A Bennett, Yiping Chen, Caixia Dong, Ruying Hu, 
Gang Zhou, Bo Yu, Weifang Jia, Sarah Parish, Robert Clarke, George Davey Smith, Rory Collins, Michael V Holmes, Liming Li†, Richard Peto†, 
Zhengming Chen†, for the China Kadoorie Biobank Collaborative Group‡
Summary
Background Moderate alcohol intake has been associated with reduced cardiovascular risk in many studies, in 
comparison with abstinence or with heavier drinking. Studies in east Asia can help determine whether these 
associations are causal, since two common genetic variants greatly affect alcohol drinking patterns. We used these 
two variants to assess the relationships between cardiovascular risk and genotype-predicted mean alcohol intake in 
men, contrasting the findings in men with those in women (few of whom drink).
Methods The prospective China Kadoorie Biobank enrolled 512 715 adults between June 25, 2004, and July 15, 2008, 
from ten areas of China, recording alcohol use and other characteristics. It followed them for about 10 years 
(until Jan 1, 2017), monitoring cardiovascular disease (including ischaemic stroke, intracerebral haemorrhage, and 
myocardial infarction) by linkage with morbidity and mortality registries and electronic hospital records. 
161 498 participants were genotyped for two variants that alter alcohol metabolism, ALDH2-rs671 and ADH1B-
rs1229984. Adjusted Cox regression was used to obtain the relative risks associating disease incidence with self-
reported drinking patterns (conventional epidemiology) or with genotype-predicted mean male alcohol intake (genetic 
epidemiology—ie, Mendelian randomisation), with stratification by study area to control for variation between areas 
in disease rates and in genotype-predicted intake.
Findings 33% (69 897/210 205) of men reported drinking alcohol in most weeks, mainly as spirits, compared with only 
2% (6245/302 510) of women. Among men, conventional epidemiology showed that self-reported alcohol intake had 
U-shaped associations with the incidence of ischaemic stroke (n=14 930), intracerebral haemorrhage (n=3496), and 
acute myocardial infarction (n=2958); men who reported drinking about 100 g of alcohol per week (one to two drinks 
per day) had lower risks of all three diseases than non-drinkers or heavier drinkers. In contrast, although genotype-
predicted mean male alcohol intake varied widely (from 4 to 256 g per week—ie, near zero to about four drinks per 
day), it did not have any U-shaped associations with risk. For stroke, genotype-predicted mean alcohol intake had a 
continuously positive log-linear association with risk, which was stronger for intracerebral haemorrhage (relative risk 
[RR] per 280 g per week 1·58, 95% CI 1·36–1·84, p<0·0001) than for ischaemic stroke (1·27, 1·13–1·43, p=0·0001). 
For myocardial infarction, however, genotype-predicted mean alcohol intake was not significantly associated with risk 
(RR per 280 g per week 0·96, 95% CI 0·78–1·18, p=0·69). Usual alcohol intake in current drinkers and genotype-
predicted alcohol intake in all men had similarly strong positive associations with systolic blood pressure (each 
p<0·0001). Among women, few drank and the studied genotypes did not predict high mean alcohol intake and were 
not positively associated with blood pressure, stroke, or myocardial infarction.
Interpretation Genetic epidemiology shows that the apparently protective effects of moderate alcohol intake against 
stroke are largely non-causal. Alcohol consumption uniformly increases blood pressure and stroke risk, and appears 
in this one study to have little net effect on the risk of myocardial infarction.
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and Wellcome Trust.
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Introduction
Although high alcohol intake is dangerous,1 in many 
prospective studies moderate intake (about one to 
two drinks per day, or 100 g of alcohol per week) is 
associated with somewhat lower incidence of stroke and 
myocardial infarction than no alcohol intake.2–6 However, 
these apparently protective associations do not necessarily 
mean that moderate alcohol intake itself is protective 
against either condition. For, poor health might affect 
alcohol consumption (reverse causality), and other 
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systematic differences might exist between people with 
different drinking patterns that were not fully allowed for 
(residual confounding).7,8 Small, short-term randomised 
trials9–11 have shown that alcohol intake causes changes 
in physio logical factors such as blood pressure, HDL 
cholesterol, adiponectin, and fibrinogen, but such trials 
cannot reliably assess realistic effects on the inci dence of 
stroke or myocardial infarction.
The question of whether there are any real protective 
effects of moderate alcohol intake can be investigated 
genetically (by Mendelian randomisation),12,13 particularly 
in populations where there are common genetic variants 
that alter alcohol metabolism but, since few women 
drink, strongly influence alcohol intake only in men. 
Alcohol is metabolised to acetaldehyde, which can cause 
discomfort if too much accumulates before it is broken 
down (panel, table 1), and there are genetic variants 
that importantly affect acetaldehyde formation and 
breakdown.14
The ALDH2-rs671 variant, which is common only in east 
Asian populations, greatly slows acetaldehyde breakdown, 
and the resulting accumulation of acetaldehyde can cause 
severe discomfort that strongly reduces alcohol intake. 
Studies of this variant have confirmed the trial evidence 
that alcohol causally affects blood pressure and some other 
physiological traits.15–17 A less important genetic variant, 
ADH1B-rs1229984, accelerates alcohol conversion to 
acetaldehyde and reduces alcohol intake.
Using data from the nationwide China Kadoorie 
Biobank prospective study, we investigated the causal 
relationships between alcohol and cardiovascular disease 
by comparing the findings from conventional epidemi-
ology (classifying people by self-reported intake) and from 
genetic epi demiology (using these two variants to classify 
people by genotype-predicted mean alcohol intake). Since 
few Chinese women drink, these genetic variants can be 
used to predict large absolute differences in mean alcohol 
intake in men, but not in women. Hence, if alcohol itself 
Research in context
Evidence before this study
Although conventional epidemiological studies have associated 
moderate alcohol intake with a reduced risk of stroke and, 
particularly, coronary heart disease, these apparently protective 
effects may be largely non-causal. Since genetic variants have 
only limited effects on alcohol intake in populations of 
European descent, studies in such populations cannot directly 
compare the effects of moderate alcohol intake with those of 
near-total alcohol avoidance. The question of whether moderate 
intake really is protective can be addressed by genetic 
epidemiology in east Asian populations where two common 
genetic variants (ALDH2-rs671 and ADH1B-rs1229984) jointly 
cause large absolute differences in mean alcohol intake.
To review the genotypic evidence about the relationships 
between vascular disease and these two genetic variants, 
we searched PubMed from database inception to Jan 11, 2019, 
for studies that had investigated the effects of either variant on 
alcohol exposure or cardiovascular disease, using the search 
terms (“alcohol” or “blood pressure” or “cholesterol” or 
“cardiovascular” or “stroke” or “myocardial infarction” or 
“coronary”) and ([“ADH1B” or “ALDH2” or “rs1229984” or 
“rs671”] or [(“East Asian” or “Chinese” or “Japanese” or 
“Korean”) and “genome-wide”]).
In meta-analyses, the incidence of coronary heart disease 
appears to be increased by the rs1229984 genotype that 
increases alcohol exposure, but, conversely, may be decreased 
by the rs671 genotype that increases alcohol exposure. There is 
insufficient evidence about the effects of these two genetic 
variants on stroke.
Added value of this study
Our large prospective study is of a population where both 
variants are common but, as few women drink, strongly affect 
alcohol exposure in only one sex. To help assess causal effects of 
alcohol on the incidence of ischaemic stroke, haemorrhagic 
stroke, and myocardial infarction, it compares the findings 
from conventional epidemiological analyses and from genetic 
analyses (which use Mendelian randomisation to study the 
effects of genetic variants that strongly influence mean male 
alcohol intake). Consistent with previous studies, the 
conventional analyses among men found U-shaped 
associations of self-reported alcohol intake with stroke and 
myocardial infarction, with the lowest risks at moderate intake.
In contrast, although genotype-predicted mean male alcohol 
intake varied from near zero to about four drinks per day, it did 
not have U-shaped associations with risk, and was strongly 
positively associated throughout its range with blood pressure, 
ischaemic stroke, and haemorrhagic stroke, suggesting no 
substantial protective effect of moderate alcohol intake. Based 
on a smaller number of cases, genotype-predicted mean male 
alcohol intake had no apparent association with myocardial 
infarction.
Among women, alcohol intake was low and these genetic 
variants had little effect on stroke or on myocardial infarction, 
suggesting that they did not have any substantial non-alcohol-
mediated (ie, pleiotropic) net effect on these diseases.
Implications of all the available evidence
Genetic evidence shows that the apparently protective effects 
of moderate alcohol intake against stroke are not mainly 
caused by alcohol itself, and are largely artifacts of reverse 
causation and confounding. Throughout the range of mean 
intake that we studied by Mendelian randomisation, increasing 
mean alcohol intake uniformly increases blood pressure and 
stroke incidence. Among the men in this population, alcohol 
was responsible for about 8% of ischaemic strokes and 16% of 
intracerebral haemorrhages. The effects of alcohol on 
myocardial infarction are less certain.
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substantially affects the incidence of stroke or myocardial 
infarction then these two genetic variants should affect 
disease incidence differently in men and in women.
Methods
Study design and participants
The China Kadoorie Biobank18 is a prospective cohort 
study of 512 715 adults recruited between June 25, 2004, 
and July 15, 2008, from ten diverse rural and urban areas 
of China. All permanent residents (aged 35–74 years) 
without known major disabilities were to be invited into 
the baseline survey, and 499 500 (28% of 1 801 167 invitees) 
participated, along with 13 215 who were just outside the 
target age range. Ethics approval was obtained from 
relevant local, national, and international ethics com-
mittees, and all participants provided written informed 
consent.
At baseline, participants attended survey clinics where 
interviewers using laptop-based questionnaires recorded 
socio economic status, medical history, smoking, drinking, 
diet, and physical activity. Measurements included height 
(sitting and standing), weight, waist and hip circumference, 
heart rate, and blood pressure. A non-fasting blood sample 
was collected for long-term storage. Similar procedures 
were followed at two separate resurveys of 4–5% of all 
participants (resurveying 19 786 between May 26, 2008, 
and Oct 10, 2008, and 25 041 between Aug 4, 2013, and 
Sept 18, 2014).
Alcohol drinking patterns
Past and current alcohol drinking patterns were self-
reported.19 Participants were classified as current drinkers 
(some alcohol use in most weeks in the past year), non-
drinkers (no alcohol use in the past year and never drank 
in most weeks), occasional drinkers (oc casional alcohol 
use in the past year but never drank in most weeks), or 
ex-drinkers (none or occasional alcohol use in the past 
year but previously drank in most weeks). In current 
drinkers, baseline alcohol intake (from main beverage 
type, amount, and frequency) was subclassified according 
to sex: for men, the groupings were less than 140, 140–279, 
280–419, and 420 or more g per week and for women, less 
than 70 and 70 or more g per week. For each of these 
baseline-defined groups the usual alcohol intake was 
estimated from intake at the resurveys. Further details of 
alcohol assessment are described in the appendix (p 4).
Follow-up for incident cardiovascular disease
Incident cardiovascular disease and cause-specific mor-
tality were ascertained through ongoing linkage, via the 
unique national identification number, to electronic 
hospital records from the nationwide health insurance 
system (which has >98% coverage across the ten study 
areas), to established local registries of stroke and coronary 
heart disease, and to local death registries. The insurance 
records included information about every hospital ad-
mission, and evidence of cardiovascular disease was 
reviewed and coded according to the International 
Classification of Diseases, tenth revision. The diseases 
analysed were ischaemic stroke, intracerebral haemor-
rhage, total stroke, acute myocardial infarction, and total 
coronary heart disease (first non-fatal or fatal record of 
each; appendix p 4).
Panel: Alcohol, acetaldehyde, and the east Asian flushing syndrome
The major clearance pathway for blood alcohol is that an alcohol dehydrogenase (ADH), 
mainly ADH1, oxidises it to acetaldehyde, which causes discomfort at sufficient 
concentrations. An aldehyde dehydrogenase (ALDH), mainly ALDH2, then detoxifies the 
acetaldehyde (oxidising it to acetate, which does not cause discomfort). Fast clearance of 
alcohol or, particularly, slow breakdown of acetaldehyde can cause individuals to limit 
alcohol intake.
In African and European populations, acetaldehyde is broken down quickly enough to 
maintain tolerably low concentrations in drinkers. In east Asian populations, there is a 
common loss-of-function variant of the ALDH2 gene on chromosome 12 (rs671). Even a 
single copy decreases acetaldehyde breakdown enough for the concentration to become 
uncomfortably high after drinking alcohol. This variant is an important determinant of the 
east Asian flushing reaction to alcohol, and of alcohol intake. Less importantly, a genetic 
variant of the ADH1B gene on chromosome 4 (rs1229984) that is common in east Asia 
increases alcohol clearance rates. Together, these two single nucleotide polymorphisms 
strongly affect alcohol exposure (table 1), and each has been shown to decrease 
substantially the incidence of alcoholism.
Both variants involve a G→A mutation, with the A allele decreasing alcohol exposure. 
Each variant has three possible genotypes, AA, AG, and GG, so the two variants define 
nine possible genotypes. Alcohol intake is affected more by the decreased rate of 
breakdown of acetaldehyde than by the increased alcohol clearance rate. Hence, when 
describing these nine genotypes the rs671 genotype is given first and the rs1229984 
genotype second, and alphabetic order corresponds to increasing alcohol intake: 
AA/AA, AA/AG, AA/GG; then AG/AA, AG/AG, AG/GG; then GG/AA, GG/AG, GG/GG.
Alcohol               acetaldehyde               acetate
ADH ALDH
ALDH2 gene ADH1B gene
Enzyme* ALDH2, an aldehyde dehydrogenase ADH1, an alcohol dehydrogenase
Enzyme function Acetaldehyde breakdown, by oxidation 
to acetate
Alcohol breakdown, by oxidation 
to acetaldehyde
Description of variants
SNP identifier rs671 rs1229984
Nucleotide change G→A G→A
Amino acid change† Glu504→Lys Arg48→His
Enzyme activity change Decreased substantially Increased substantially
Alcohol clearance rate Unaffected Accelerated
Acetaldehyde clearance rate Decreased substantially Unaffected
Alcohol intake Reduced substantially Reduced‡
ALDH=aldehyde dehydrogenase. ADH=alcohol dehydrogenase. SNP=single nucleotide polymorphism. *ALDH2 is a 
tetramer of the ALDH2 gene product that requires all four parts to be functional, so a loss-of-function variant is nearly 
dominant. ADH1 is a dimer that requires two functional parts from the products of any of three similar genes, ADH1A, 
ADH1B, and ADH1C. †For ALDH2 and ADH1B, each of these amino acid changes can be described as altering the “*1” 
into the “*2” enzyme isoform. ‡The ADH1B-rs1229984 east Asian variant is nearly dominant, with AA and AG having 
similar effects on alcohol intake.
Table 1: Two east Asian genetic variants that alter alcohol metabolism
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Genotyping and biochemistry
161 498 participants were genotyped for the two variants of 
interest, rs671 and rs1229984, using custom Illumina 
Golden Gate or Affymetrix Axiom arrays at BGI (Shenzhen, 
China). They included 151 028 randomly selected partic-
ipants (used in all genetic analyses) and an additional 
10 470 participants (used only in analyses of stroke and 
coronary heart disease) who had been selected because 
during follow-up they had had a stroke or coronary heart 
disease recorded.
18 256 participants (who had been selected for nested 
case-control studies of stroke and of coronary heart 
disease) were assayed for plasma HDL cholesterol, 
LDL cholesterol, triglycerides, lipoprotein(a), C-reactive 
protein, fibrinogen, and γ-glutamyl transferase at the 
Wolfson Laboratory (Clinical Trial Service Unit, Oxford, 
UK). Of them, 98% (17 874) were among those genotyped 
for the above two variants. Further details of genotyping 
and biochemistry are in the appendix (p 4).
Mean alcohol intake by genotype and area
Combinations of the genotypes for the two genetic 
variants of interest (rs671 and rs1229984; each AA, AG, 
or GG) define nine genotypes (panel). Since alcohol use 
varies greatly by study area,19 in each of the ten study 
areas mean male alcohol intake was calculated for each 
of these nine genotypes (assigning occasional drinkers 
an intake of 5 g per week and excluding ex-drinkers, 
which effectively assigns them the mean intake in other 
partic ipants in their area). The 90 combinations of 
genotype and area were subdivided into six categories 
(1–6) according to these 90 mean values, with cutoff 
points of 10, 25, 50, 100, and 150 g per week (figure 1). 
Classification of individual participants into the six 
categories was dependent only on their genotype and 
study area, not on their individual drinking patterns. 
Women were clas sified into the same six cat egories 
of genotype and area as men, regardless of their drinking 
patterns, to facilitate compar ison between genotypic 
effects in men and in women.
Statistical analysis
General linear models were used to assess associations 
with continuous variables (eg, systolic blood pressure), 
giving the adjusted mean values in each of several 
exposure groups. These exposure groups were defined 
either by self-reported alcohol drinking patterns or by 
categories of genotype and area. Cox regression was used 
to assess associations with disease rates, giving the relative 
risks (RRs) of disease incidence in each exposure group, 
after specifying one of these as the reference group 
(RR=1). The variance of the log risk in each group, 
including the reference group, was calculated (from the 
variances and covariances of the log RRs in all groups 
except the reference group) and used to obtain group-
specific 95% CIs.20 Participants with a previous history of 
coronary heart disease, stroke, or transient cerebral 
ischaemia were excluded from the analyses of disease 
incidence. Analytic models and sensitivity ana lyses are 
described in the appendix (pp 5, 6).
Figure 1: Mean alcohol intake in men from ten study areas in China, subdivided by nine possible genotypes of two common variants that alter alcohol metabolism
For each genotype, the A allele discourages alcohol consumption. Within each area, mean alcohol intake was plotted according to the nine possible ALDH2-rs671 and 
ADH1B-rs1229984 genotypes (each AA, AG, or GG) from AA/AA homozygosity for both variants to GG/GG homozygosity for both variants. Alcohol intake thresholds 
were defined at 10, 25, 50, 100, and 150 g per week to assign individuals into six categories of mean male alcohol intake on the basis of their genotype and area.
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Conventional epidemiological analyses related individual 
drinking patterns to physiological factors, or to the RRs for 
disease. They were adjusted for area, age, education, 
income, and smoking. To avoid the regression dilution 
bias,21 among current drinkers the means or log RRs were 
plotted against the usual alcohol intake, along with straight 
lines of best fit. The slopes of these lines were described in 
terms of the change in the mean, or in the RR, per 280 g 
per week (ie, around four drinks per day) usual alcohol 
intake. Occasionally the RR per 100 g per week was also 
calculated, as described in the appendix (p 6).
Genetic epidemiological analyses related genotype and 
study area (categorised as described above) to physiological 
factors, or to the RRs for disease. These analyses were 
stratified by area (so any differences in outcome between 
the six categories of genotype and study area reflect purely 
genotypic effects) and were adjusted only for age (although 
sensitivity analyses also adjusted them for education, 
income and smoking). Means or log RRs were plotted 
against the mean alcohol intake among the men in each 
of the six categories. Within each study area a similar 
analysis was done, and then the slope of the straight line 
of best fit related outcome to exposure in that one area. To 
obtain a meta-analysis of these within-area slopes (each 
reflecting purely genotypic effects), an inverse-variance 
weighted mean of them yielded the overall slope, stratified 
by area. Slopes were described in terms of the change in 
the mean, or in the RR, per change of 280 g per week in 
genotype-predicted mean male alcohol intake.
Genotypic analyses in women were done not to assess 
the effects of alcohol in women (since women’s alcohol 
intake was known to be minimal), but to determine the 
extent to which the genotypes studied in men had 
pleiotropic effects12 (ie, effects of the genotype that were 
not mediated by drinking patterns). Hence, we used the 
same six categories of genotype and area as in men, 
relating the area-adjusted genotypic effects in women to 
the mean male alcohol intake in these six categories.
For men and for women we also calculated as sensitivity 
analyses (stratified by area and adjusted for age) the 
separate genotypic effects of each of the two variants. 
SAS (version 9.3) and R (version 3.2.1) were used for all 
statistical analyses.
Role of the funding source
The funders of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. IYM, RGW, LL, RP, and ZC had access to all 
data and had final responsibility for the decision to submit 
for publication.
Results
From the ten study areas, 512 715 participants were 
enrolled (226 182 urban and 286 533 rural residents, 
mean age 52 years [SD 11]) and followed for incident 
cardiovascular disease. By Jan 1, 2017, after around 
10 years of follow-up, 4781 (0·9%) had been lost and 
44 037 (8·6%) had died. At baseline, 33% (69 897/210 205) 
of the men and 2% (6245/302 510) of the women reported 
drinking some alcohol in most weeks, mainly as spirits, 
but there was wide variation in the prevalence of drinking 
across study areas (appendix pp 11, 12).
For 161 498 of the participants two G→A single-
nucleotide polymorphisms that alter alcohol me tabolism 
were genotyped (rs671 and rs1229984; panel). For rs671 the 
overall A-allele frequency was 0·21 (range by area 
0·13–0·29) and for rs1229984 it was 0·69 (0·64–0·74), with 
both A-alleles tending to be more common in southern 
than in northern study areas (appendix p 13). For each 
variant, the genotype frequencies within each area were 
consistent with Hardy-Weinberg equilibrium.
The more important variant, rs671, strongly affected 
drinking patterns: among men, mean alcohol intake with 
its AA, AG, and GG genotype was 3, 37, and 157 g per 
week, respectively, and the proportion of current drinkers 
was 1%, 16%, and 45%. The other variant, rs1229984, had 
a definite but smaller effect: among men, mean alcohol 
intake with its AA, AG, and GG genotype was 98, 106, 
Figure 2: Patterns of alcohol use in six categories of genotype and study area
Prevalence of ever drinking, defined as some alcohol in most weeks (A), and mean 
weekly alcohol intake (B) in six categories of genotype and study area.
3%
<1%
15%
<1%
20%
<1%
39%
2%
60%
5%
74%
6%
4 g <2 g
18 g
<2 g
34 g
<2 g
78 g
4 g
130 g
5 g
256 g
8 g
1 2 6543
0
100
200
300
M
ea
n 
al
co
ho
l i
nt
ak
e 
(g
 p
er
 w
ee
k)
Category
0
20
40
60
80
100
Pr
op
or
tio
n 
of
 p
ar
tic
ip
an
ts
 e
ve
r d
rin
ki
ng
 a
lco
ho
l i
n 
m
os
t w
ee
ks
 (%
) Current drinker (men)
Ex-drinker (men)
Current drinker (women)
Ex-drinker (women)
Men
Women
A
B
Prevalence of ever drinking in most weeks
Mean weekly alcohol intake
Articles
1836 www.thelancet.com   Vol 393   May 4, 2019
and 157 g per week, respectively, and the proportion of 
current drinkers was 32%, 33%, and 43%. Among current 
drinkers, each variant was associated with flushing after 
drinking a small amount of alcohol, but the effect was 
much stronger with rs671 (appendix p 14).
Combinations of the rs671 genotype (AA, AG, or GG) 
and the rs1229984 genotype define nine possibilities for 
the joint rs671/rs1229984 genotype (panel). When written 
in alphabetic order from AA/AA to GG/GG, within each 
of the ten study areas these nine genotypes tended to 
involve progressively increasing mean male alcohol 
intake, with larger absolute differences between genotypes 
in areas where average intake was higher (figure 1). 
In Sichuan (the area with the highest levels of alcohol 
consumption) mean male alcohol intake ranged from 2 g 
per week for individuals with the AA/AA genotype to 
443 g per week for those with the GG/GG genotype, 
whereas in Gansu (the area with the lowest levels of 
alcohol consumption) it ranged from 1 g per week to only 
29 g per week (appendix p 15).
Figure 1 shows how the 90 combinations of genotype 
and study area were divided into six categories, depending 
on the mean male alcohol intake in each combination. 
The prevalence of drinking was more than 20 times 
higher in category 6 than in category 1, and mean alcohol 
intake was more than 50 times higher (figure 2). 
Comparisons between these six categories can, as long 
as they are stratified by area, be used to estimate purely 
genotypic effects on disease rates and other factors. 
Apart from the large differences in drinking patterns there 
Figure 3: Associations of physiological factors with drinking patterns and with genotypic determinants of mean alcohol intake, in men
Conventional epidemiological analyses (A–C) relate self-reported drinking patterns at baseline to mean systolic blood pressure (A), HDL cholesterol (B), and γ-glutamyl 
transferase (C). Results are adjusted for age, area, education, income, and smoking. The means for current drinkers are plotted against usual alcohol intake, with a fitted 
line giving the slope (95% CI) per 280 g alcohol per week. Genetic epidemiological analyses (D–F) ignore individual drinking patterns, and for all men relate mean 
alcohol intake in six categories of genotype and study area to genotypic effects on mean systolic blood pressure (D), HDL cholesterol (E), and γ-glutamyl transferase (F). 
Results are adjusted for age and area. The slope of the fitted line is the inverse-variance-weighted mean of the slopes of the fitted lines in each study area. The area of 
each square in A–F is inversely proportional to the variance of the result. Error bars show 95% CIs.
No
n-d
rin
ke
r
Ex-
dri
nk
er
Oc
cas
ion
al d
rin
ke
r 100 200 300 400 500
0
128
130
132
134
136
138
M
ea
n 
sy
st
ol
ic 
bl
oo
d 
pr
es
su
re
 (m
m
 H
g)
A Systolic blood pressure
Conventional epidemiological analyses
Alcohol intake of current drinkers
(g per week)
No
n-d
rin
ke
r
Ex-
dri
nk
er
Oc
cas
ion
al d
rin
ke
r 100 200 300 400 500
0
1·0
1·1
1·2
1·3
1·4
1·5
M
ea
n 
H
DL
 ch
ol
es
te
ro
l c
on
ce
nt
ra
tio
n 
(m
m
ol
/L
)
B HDL cholesterol
Alcohol intake of current drinkers
(g per week)
(n=193 003)
4·8 (95% CI 4·5–5·1)
per 280 g per week
p<0·0001
0·19 (95% CI 0·17–0·22)
per 280 g per week
p<0·0001
(n=9238)Ever ≥weekly
Never ≥weekly
1000 200 300 400 500
0
128
130
132
134
136
138
M
ea
n 
sy
st
ol
ic 
bl
oo
d 
pr
es
su
re
 (m
m
 H
g)
D Systolic blood pressure
Mean alcohol intake predicted 
from genotype and area (g per week)
(n=55 897)
4·3 (95% CI 3·7–4·9)
per 280 g per week
p<0·0001
No
n-d
rin
ke
r
Ex-
dri
nk
er
Oc
cas
ion
al d
rin
ke
r 100 200 300 400 500
0
20
40
60
80
100
120
140
M
ea
n 
y-
gl
ut
am
yl
 tr
an
sf
er
as
e 
co
nc
en
tr
at
io
n 
(IU
/L
)
C γ-glutamyl transferase
Alcohol intake of current drinkers
(g per week)
(n=8574)
62 (95% CI 54–70)
per 280 g per week
p<0·0001
1000 200 300 400 500
0
20
40
60
80
100
120
140
M
ea
n 
y-
gl
ut
am
yl
 tr
an
sf
er
as
e 
co
nc
en
tr
at
io
n 
(IU
/L
)
F γ-glutamyl transferase
Mean alcohol intake predicted 
from genotype and area (g per week)
(n=8386)
44 (95% CI 36–53)
per 280 g per week
p<0·0001
1000 200 300 400 500
0
1·0
1·1
1·2
1·3
1·4
1·5
1·6
M
ea
n 
H
DL
 ch
ol
es
te
ro
l c
on
ce
nt
ra
tio
n 
(m
m
ol
/L
)
E HDL cholesterol
Mean alcohol intake predicted 
from genotype and area (g per week)
(n=9040)
0·16 (95% CI 0·13–0·19)
per 280 g per week
p<0·0001
Genetic epidemiological analyses
Articles
www.thelancet.com   Vol 393   May 4, 2019 1837
were no large genotype-dependent differences between 
these six categories in smoking or in other self-reported 
baseline characteristics (appendix p 19).
Subsequent analyses compared conventional epidemiol-
ogical analyses (relating individual drinking patterns to 
various factors) and genetic epidemiological analyses 
(which ignore individual drinking patterns, and for all 
men relate differences between the six categories in mean 
alcohol intake to genotype-dependent differences between 
them in other factors). Among men, blood pressure and 
the concentrations (where available) of HDL cholesterol 
and γ-glutamyl transferase were positively associated 
with alcohol intake in both conventional and genetic 
epidemiological analyses (all p<0·0001; figure 3). Among 
current drinkers, the mean alcohol intake was about 280 g 
per week (appendix p 12) and systolic blood pressure 
increased by 4·8 mm Hg (95% CI 4·5–5·1) per 280 g 
per week usual alcohol intake. Similarly, systolic blood 
pressure increased by 4·3 mm Hg (3·7–4·9) per 280 g 
per week genotype-predicted mean alcohol intake. The 
increase in HDL cholesterol per 280 g per week alcohol 
intake was also similar in the conventional and in the 
genetic analyses. Associations with other physiological 
factors are shown in the appendix (p 21).
For male stroke rates, however, conventional and 
genetic epidemiological analyses yielded very different 
Figure 4: Associations of stroke incidence with drinking patterns and with genotypic determinants of alcohol intake, in men
Conventional epidemiological analyses (A–C) relate self-reported drinking patterns at baseline to the incidence of ischaemic stroke (A), intracerebral haemorrhage (B), 
and total stroke (C). Current drinkers with the lowest mean alcohol intake are the reference group (RR=1), and results are adjusted for age, area, education, income, and 
smoking. The RRs for current drinkers are plotted against usual alcohol intake, with a fitted line giving the RR (95% CI) per 280 g intake per week. Genetic epidemiological 
analyses (D–F) ignore individual drinking patterns, and for all men relate mean alcohol intake in six categories of genotype and study area to genotypic effects on the 
incidence of ischaemic stroke (D), intracerebral haemorrhage (E), and total stroke (F). The category with the lowest mean alcohol intake is the reference group (RR=1), 
and results are adjusted for age and area. The slope of the fitted line is the inverse-variance-weighted mean of the slopes of the lines of best fit within the ten study areas. 
The RR is plotted on a log scale and the area of each square is inversely proportional to the variance of the log risk. The group-specific 95% CIs, calculated from this 
variance, are shown by error bars. RR=relative risk.
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findings. In the conventional epidemiological analyses of 
stroke incidence rates among men, self-reported alcohol 
intake had a U-shaped association with the incidence of 
ischaemic stroke, intracerebral haemorrhage, and total 
stroke (figure 4). Moderate alcohol intake (about 100 g 
per week) was associated with a risk of stroke lower than 
that in non-drinkers or, particularly, ex-drinkers. Among 
current drinkers, stroke risk increased with the usual 
alcohol intake, with a smaller proportional increase for 
ischaemic stroke (RR per 280 g per week 1·28, 95% CI 
1·19–1·38, p<0·0001) than for intracerebral haemorrhage 
(1·59, 1·37–1·85, p<0·0001; p=0·01 for the difference 
between these RRs). U-shaped associations with alcohol 
intake persisted in sensitivity analyses that excluded early 
follow-up, ever-smokers, and people with poor self-
reported health at baseline (appendix pp 23, 24).
In the genetic epidemiological analyses, however, 
there were no U-shaped associations with stroke risk 
and there was no evidence of any protective effects of 
moderate alcohol intake against ischaemic stroke, 
intracerebral haemor rhage, or total stroke (figure 4). 
Stroke risk increased steadily across the whole range of 
genotype-predicted mean male alcohol intake (4–256 g 
per week), again with a smaller proportional increase for 
ischaemic stroke (RR per 280 g per week 1·27, 95% CI 
1·13–1·43, p=0·0001) than for intracerebral haemorrhage 
(1·58, 1·36–1·84, p<0·0001; p=0·01 for the difference 
between these RRs) or total stroke (1·38, 1·26–1·51). The 
mean intake in all men was about 100 g per week 
(appendix p 12), and the corresponding RRs per 100 g 
per week were 1·09 (1·04–1·14), 1·18 (1·12–1·24), and 
1·12 (1·09–1·16), respectively. Adjusting for potential 
confounders in sensitivity analyses did not materially 
change the results (appendix p 25).
The genotypic analyses provided no suggestion of 
increased stroke risk at very low levels of alcohol intake 
(although in the first of the six categories two-thirds were 
non-drinkers), or of any material deviation from log-
linear relationships (figure 4). Even if, for statistical 
stability, the three categories with the lowest alcohol 
intake (categories 1–3, mean male intake around 25 g per 
week) were pooled and compared with categories 4 and 5 
(mean male intake around 100 g per week), the genotypic 
analyses still indicated adverse rather than protective 
effects of moderate alcohol intake against ischaemic 
stroke and against intracerebral haemorrhage (appendix 
p 26). The corresponding genotypic findings within each 
separate study area were directionally consistent with 
each other, and with the overall findings (appendix p 28). 
For blood pressure and for stroke, the slopes of the lines 
in figures 3 and 4 appeared to be greater for men younger 
than age 60 years at baseline than for other men, but the 
numbers were insufficient for this dependence on age to 
be reliable (appendix p 30).
For male coronary heart disease, conventional epidemi-
ology and genetic epidemiology again yielded different 
findings (figure 5). In the conventional epide miological 
analyses, there were U-shaped associations with risk. 
Moderate alcohol intake was associated with rates of 
acute myocardial infarction and of total coronary heart 
disease that were substantially lower than the rates in 
non-drinkers or ex-drinkers (and this apparently 
protective effect of moderate versus no alcohol intake 
persisted in sensitivity analyses; appendix p 32). Among 
current drinkers, usual alcohol intake was weakly 
positively associated with heart disease; the RR per 280 g 
per week was 1·15 (95% CI 0·96–1·38, p=0·14) for acute 
Figure 5: Associations of coronary heart disease incidence with drinking patterns and with genotypic 
determinants of alcohol intake, in men
Conventional epidemiological analyses (A–B) relate self-reported drinking patterns at baseline to the incidence of 
acute myocardial infarction (A) and total coronary heart disease (B). Current drinkers with the lowest mean alcohol 
intake are the reference group (RR=1), and results are adjusted for age, area, education, income, and smoking. The RRs 
for current drinkers are plotted against usual alcohol intake, with a fitted line giving the RR (95% CI) per 280 g intake 
per week. Genetic epidemiological analyses (C–D) ignore individual drinking patterns, and for all men relate mean 
alcohol intake in six categories of genotype and area to genotypic effects on the incidence of acute myocardial 
infarction (C) and total coronary heart disease (D). The category with the lowest mean alcohol intake is the reference 
group (RR=1), and results are adjusted for age and area. The slope of the fitted line is the inverse-variance-weighted 
mean of the slopes of the lines of best fit within the ten study areas. The RR is plotted on a log scale and the area of 
each square is inversely proportional to the variance of the log risk. The group-specific 95% CIs, calculated from this 
variance, are shown by error bars. RR=relative risk.
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myocardial infarction and 1·12 (1·04–1·21, p=0·003) for 
total coronary heart disease.
In the genetic epidemiological analyses, however, 
there was no clear evidence of any net protective effect of 
moderate alcohol consumption against acute myocardial 
infarction or total coronary heart disease (figure 5). 
Across the whole range of genotype-predicted mean 
male alcohol intake, the RR per 280 g per week was 0·96 
(95% CI 0·78–1·18, p=0·69) for acute myocardial 
infarction and 1·05 (0·94–1·17, p=0·40) for total 
coronary heart disease.
Among women, mean alcohol intake was low in all 
six categories of genotype and area (figure 2). Hence, any 
genotypic effects of these categories that are mediated by 
drinking patterns should be much smaller in women 
than in men, but any other (ie, pleiotropic) genotypic 
effects of them should be comparable in both sexes. To 
assess any pleiotropic effects on physiological factors or 
disease rates, the findings in men and in women are 
compared (table 2), relating the genotypic effects in 
both sexes to the mean alcohol intake only in men. 
Among women, systolic blood pressure, HDL cholesterol, 
γ-glutamyl transferase, is chaemic stroke, intracerebral 
haemorrhage, and acute myocardial infarction were not 
adversely associated with the genotypes that increase 
alcohol intake in men—indeed, blood pressure was, if 
anything, slightly favourably affected. After allowance for 
multiple testing, no material genotypic effects on other 
physiological factors were identified in women, except 
for increases of a few mm per allele in height, waist, and 
hip measurements (appendix p 21).
Sensitivity analyses considered the two genetic variants 
separately (appendix pp 36–40). Among women, there 
were no significant associations of either variant with 
stroke or heart disease. The following results involve 
only men, and assess the effects of a single copy of 
the variant allele. For rs671, participants with the GG 
genotype had substantially higher mean alcohol intake, 
systolic blood pressure, HDL cholesterol, and γ-glutamyl 
transferase than did those with the AG genotype, and 
had a definite excess risk of stroke (GG vs AG: RR 1·19, 
1·13–1·24, p<0·0001), though not of myocardial in-
farction (1·02, 0·92–1·13). For rs1229984, the effects on 
alcohol intake and on these three physiological factors 
were only about half as great, but again there was a 
definite excess risk of stroke (GG vs AG: RR 1·19, 
1·11–1·27, p<0·0001), but not of myocardial infarction 
(1·11, 0·95–1·31).
Discussion
Our aim is to assess causal effects of alcohol intake that 
should be of general relevance in any population, not 
just effects of particular genotypes in one east Asian 
population. Nevertheless, genotypic studies in China can 
provide generally relevant evidence about causal effects of 
alcohol intake. For, two genetic variants that greatly alter 
alcohol metabolism are common in China, the more 
important of which (rs671) reduces alcohol intake to 
almost zero in both sexes. In our population men drink 
more than 20 times as much as women, so these two 
variants have large absolute effects on alcohol intake only 
among men. This permits reliable comparison of the 
Systolic blood pressure 
(mm Hg)
HDL cholesterol 
(mmol/L)
γ-glutamyl 
transferase (IU/L)
Ischaemic stroke 
(RR)
Intracerebral haemorrhage 
(RR)
Acute myocardial infarction 
(RR)
Category of 
genotype and 
study area*
Men 
(n=55 879)
Women 
(n=83 017)
Men 
(n=9040)
Women 
(n=8754)
Men 
(n=8386)
Women 
(n=8088)
Men 
(5709 events)
Women 
(7087 events)
Men 
(2790 events)
Women 
(2525 events)
Men 
(1696 events)
Women 
(1246 events)
1 129·7 129·7 1·16 1·29 28 23 1·00 1·00 1·00 1·00 1·00 1·00
2 130·0 129·4 1·16 1·29 31 24 1·00 0·93 1·01 1·05 1·02 0·96
3 130·5 129·2 1·17 1·28 32 25 1·03 0·98 1·02 1·16 1·05 0·99
4 131·6 128·5 1·19 1·28 41 22 1·11 0·93 1·08 1·21 0·93 0·95
5 133·0 128·4 1·24 1·28 55 24 1·23 0·96 1·29 1·19 0·94 1·02
6 134·1 128·5 1·30 1·29 70 23 1·23 0·95 1·54 1·06 0·97 0·92
Effect per 
280 g per 
week mean 
MALE alcohol 
intake 
(95% CI)
4·3 
(3·7 to 4·9)
–0·6 
(–1·0 to –0·1)
0·16 
(0·13 to 0·19)
0·00 
(–0·03 to 0·03)
44 
(36 to 53)
0 
(–3 to 3)
1·27 
(1·13 to 1·43)
0·98 
(0·88 to 1·09)
1·58 
(1·36 to 1·84)
0·96 
(0·82 to 1·12)
0·96 
(0·78 to 1·18)
0·94 
(0·74 to 1·20)
p value for 
effect greater 
in men than 
women†
<0·0001 ·· <0·0001 ·· <0·0001 ·· 0·0007 ·· <0·0001 ·· 0·45 ··
RR=relative risk. *Six categories of genotype and study area; mean values of physiological factors and RRs of disease are adjusted for age and area, leaving only genotypic differences. †Genotypic effect on 
physiological factor (slope per 280 g per week mean MALE alcohol intake) or on disease incidence (RR per 280 g per week mean MALE alcohol intake); since women consumed little alcohol, comparison between 
these genotypic effects in men and in women can help assess whether the genotypic effects in men are chiefly mediated by alcohol rather than by pleiotropic pathways that influence both sexes similarly.
Table 2: Comparison between genotypic effects in men and in women
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causal effects of negligible, moderate, and higher levels of 
mean male alcohol intake. In populations of European 
descent, however, only the less important of these two 
variants (rs1229984) is found, so genetic studies13,22 cannot 
directly compare the effects of negligible and moderate 
alcohol intake levels.
Mainly for cultural rather than genetic reasons, alcohol 
intake differed substantially across our ten study areas. 
After grouping all possible combinations of genotype 
and study area into six categories according to mean 
male alcohol intake, there was wide variation between 
these six categories in mean intake, ranging from almost 
no alcohol to a mean of about 25 drinks per week 
among men. By contrast, mean alcohol intake was low 
among women in all six categories. Hence, the find-
ings among women are used mainly to show that the 
genotypic findings among men were mediated chiefly by 
alcohol rather than by any other (ie, pleiotropic) effects 
of genotype. Although the category definitions were 
dependent on both genotype and study area, the genetic 
epidemiological analyses allowed fully for area. So, the 
findings from them reflect only the effects of within-area 
differences in genotype.
A meta-analysis of the findings from conventional 
epidemiological analyses of 83 prospective studies,6 
mainly in populations of European descent, excluded 
non-drinkers and found that, among drinkers, stroke 
incidence increased steadily with the amount of alcohol 
consumed, whereas the incidence of myocardial infarction 
was slightly higher in drinkers whose usual intake was 
only 35 g per week rather than 100 g per week, and 
was approximately constant over the range of 100–350 g 
per week. Conventional epidemiological analyses of the 
present study in China are consistent with this meta-
analysis,6 and are complemented by novel genetic 
epide miological analyses that help assess causality.
Intervention studies9–11 have shown that alcohol increases 
blood pressure and HDL cholesterol. The associations 
between alcohol and these factors were strongly positive in 
our conventional epidemiological analyses among current 
drinkers (which relate usual alcohol intake to outcome) 
and were similarly strongly positive in our genetic 
epidemiological analyses (which relate genotype-predicted 
mean male alcohol intake to outcome). Both types of 
analysis indicated that 280 g per week of alcohol increases 
systolic blood pressure by about 5 mm Hg, which 
(in conventional analyses of blood pressure and risk in this 
population) is associated with increases of about 15% in 
ischaemic heart disease and ischaemic stroke, and of about 
30% in intracerebral haemorrhage.23
For ischaemic stroke and, more strongly, for 
intracerebral haemorrhage, the genetic epidemiological 
comparisons across our six categories show that risk 
increases continuously across the whole range from 
negligible to high genotype-predicted mean intake, with 
no excess risk in the first of these categories (in which 
two-thirds of individuals do not drink at all and most 
others drink only occasionally; appendix p 17). These 
comparisons also show that stroke risk is about as 
strongly positively related to genetically predicted mean 
alcohol intake as it is with the usual alcohol intake 
among current drinkers. Neither of these two findings is 
what would be expected under the hypothesis that, in 
com parison with abstinence, moderate drinking is 
substantially protective (appendix pp 41, 42). For, the 
decrease across categories in the pro portions exposed to 
the hypothesised excess risks of abstinence would 
oppose the increase across categories in the proportions 
exposed to the excess risks of heavier drinking.
Taken together, these two findings mean that the lower 
stroke risks in moderate drinkers than in non-drinkers 
that have been suggested by conventional epidemiological 
analyses of this and previous studies were not chiefly due 
to protective effects of moderate drinking, and may well 
have reflected biases of reverse causation or confounding.
If (but only if) there is no material protective effect, and 
the causal relationship of alcohol intake to stroke risk is 
approximately log-linear rather than U-shaped, then the 
genetic epidemiology provides a direct quantitative 
estimate of the strength of that causal relationship. In the 
genetic epidemiological analyses, the excess risks of 
ischaemic stroke and intracerebral haemorrhage were 
27% and 58% per 280 g alcohol per week, respectively. 
This alcohol intake is approximately the mean amount 
consumed by the one-third of all men who were current 
drinkers. Hence, the genetic findings imply that, among 
all men, alcohol was responsible for about 8% of ischaemic 
strokes and 16% of intracerebral haemorrhages. 
These excess stroke risks are about twice as great as 
expected just from the effects of alcohol on systolic blood 
pressure.23 This discrepancy might be because blood 
pressure differences due to these genetic factors persist 
throughout adult life, or because transient effects of 
alcohol on blood pressure (and hence on stroke risk) are 
greater at other times than at our daytime recruitment 
clinics, or because of adverse effects of alcohol on factors 
other than blood pressure.
For each of the two genetic variants, the A allele was 
nearly dominant in its effects on alcohol intake, physio-
logical factors, and stroke, but although the decreases in 
alcohol intake and physiological factors with one A allele 
versus none were less than half as great for rs1229984 
as for rs671, the corresponding decreases in stroke 
appeared surprisingly similar (appendix pp 44, 45). This 
apparent discrepancy may, unless it is a chance finding, 
be because rs1229984 reduces alcohol exposure both 
through reducing alcohol intake and, for a given intake, 
through accelerating alcohol clearance.
For heart disease, the genetic epidemiological analyses 
are more difficult to interpret reliably. For acute 
myocardial infarction, they suggest little net effect on 
risk over the range from near zero to about 250 g per 
week of predicted mean intake. This is what would be 
expected if moderate alcohol intake is not really 
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protective, and if (as in the meta-analysis of previous 
conventional studies6) increased intake is not really 
hazardous above the range of intakes studied. The 
number of cases of acute myocardial infarction was, 
however, limited, so some real benefit or hazard cannot 
be excluded. Considering the two variants separately, 
our findings for rs1229984 (based on small numbers) 
are consistent with previous meta-analyses in European-
origin populations,13 but our findings for rs671 do not 
support previous meta-analyses in east Asian 
populations, which suggested a moderate association 
between the alcohol-tolerant rs671 allele and decreased 
coronary heart disease risk.24,25
The lack of a positive association between genotype-
predicted alcohol intake and acute myocardial infarction 
suggests the adverse effects of alcohol intake on blood 
pressure could be offset by cardio-protective changes in 
other factors. Although HDL cholesterol increased 
substantially with alcohol intake, the causal relevance of 
different components of HDL cholesterol to coronary 
heart disease risk remain uncertain. A previous trial26 of 
the cholesteryl ester transfer protein inhibitor anacetrapib, 
which substantially increases HDL cholesterol, reported a 
coronary heart disease reduction that was no greater than 
would be expected just from the LDL-cholesterol-lowering 
effects of the drug, and in previous analyses27 of the China 
Kadoorie Biobank study, a loss-of-function variant of the 
cholesteryl ester transfer protein that substantially 
increases total HDL cholesterol had little net effect on the 
incidence of coronary heart disease.
A major limitation of all alcohol epidemiology is that 
exposure is uncertain. Drinking patterns are variable, and 
intake may be substantially underperceived or under-
reported. If mean intake was really substantially higher 
than reported, then all our conventional and genotypic 
dose-response rela tionships are too steep, and the real 
relationships are substan tially shallower. Conversely, our 
genotypic dose-response relationships would have been 
about 10% stronger if our calculations of mean intake had 
included ex-drinkers, whose previous intake was unknown, 
as having zero intake rather than the mean intake of other 
participants (appendix p 17).
Since participants reported drinking mainly spirits, 
the effects of other drinks (eg, red wine) could not be 
assessed. Although many biomarkers were measured, 
they might not capture some important mechanisms by 
which alcohol could affect myocardial infarction risk. 
The two enzymes affected by the genetic variants we 
studied are involved in many biochemical pathways, so 
increases or decreases in their activity could have multiple 
physiological effects.28,29 In women, however, there were 
no material genotypic associations with cardiovascular 
risk or physiological factors, with the exception of small 
effects on anthropometry and, perhaps, blood pressure. 
Hence, the genotypic findings in men were probably 
driven mainly by alcohol exposure rather than by 
pleiotropic effects.
The genetic epidemiological analyses in this large 
study do not support the apparently protective effects 
against stroke of moderate drinking when compared 
with no drinking that are suggested by conventional 
epidemi ological analyses. Although alcohol increases 
blood pressure, we identified no clear net association 
with acute myocardial infarction, but the number of 
cases was limited. The number of strokes, however, was 
substantial, and the genetic epidemiological analyses 
show that alcohol intake uniformly increases blood 
pressure, ischaemic stroke, and haemorrhagic stroke.
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